AML1-ETO AML derives from the translocation t (8;21) (q22; q22), creating a novel chimeric gene, RUNX1/MTG8, AML patients with this genetic abnormality usually achieve a relatively favourable prognosis [75]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.